• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人特异性、GalNAc/T/Tn 特异性和 Neu5Ac 特异性海藻糖凝集素作为 SARS-CoV-2(COVID-19)冠状病毒的聚糖探针。

Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.

机构信息

Institut de Recherche et Développement, Faculté de Pharmacie, UMR 152 PharmaDev, Université Paul Sabatier, 35 Chemin des Maraîchers, 31062 Toulouse, France.

Department of Biotechnology, Faculty of Bioscience Engineering, Ghent University, Coupure links 653, B-9000 Ghent, Belgium.

出版信息

Mar Drugs. 2020 Oct 29;18(11):543. doi: 10.3390/md18110543.

DOI:10.3390/md18110543
PMID:33138151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7693892/
Abstract

Seaweed lectins, especially high-mannose-specific lectins from red algae, have been identified as potential antiviral agents that are capable of blocking the replication of various enveloped viruses like influenza virus, herpes virus, and HIV-1 in vitro. Their antiviral activity depends on the recognition of glycoprotein receptors on the surface of sensitive host cells-in particular, hemagglutinin for influenza virus or gp120 for HIV-1, which in turn triggers fusion events, allowing the entry of the viral genome into the cells and its subsequent replication. The diversity of glycans present on the S-glycoproteins forming the spikes covering the SARS-CoV-2 envelope, essentially complex type -glycans and high-mannose type -glycans, suggests that high-mannose-specific seaweed lectins are particularly well adapted as glycan probes for coronaviruses. This review presents a detailed study of the carbohydrate-binding specificity of high-mannose-specific seaweed lectins, demonstrating their potential to be used as specific glycan probes for coronaviruses, as well as the biomedical interest for both the detection and immobilization of SARS-CoV-2 to avoid shedding of the virus into the environment. The use of these seaweed lectins as replication blockers for SARS-CoV-2 is also discussed.

摘要

海藻凝集素,特别是来自红藻的高甘露糖特异性凝集素,已被鉴定为有希望的抗病毒药物,能够在体外阻断各种包膜病毒(如流感病毒、疱疹病毒和 HIV-1)的复制。它们的抗病毒活性取决于对敏感宿主细胞表面糖蛋白受体的识别-特别是流感病毒的血凝素或 HIV-1 的 gp120,这反过来又触发融合事件,允许病毒基因组进入细胞并随后进行复制。形成覆盖 SARS-CoV-2 包膜的刺突的 S-糖蛋白上存在的聚糖的多样性,本质上是复杂型聚糖和高甘露糖型聚糖,表明高甘露糖特异性海藻凝集素特别适合作为冠状病毒的聚糖探针。本综述详细研究了高甘露糖特异性海藻凝集素的碳水化合物结合特异性,证明了它们作为冠状病毒特异性聚糖探针的潜力,以及用于检测和固定 SARS-CoV-2 以避免病毒释放到环境中的生物医学意义。还讨论了这些海藻凝集素作为 SARS-CoV-2 复制抑制剂的用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/83e3ed9617aa/marinedrugs-18-00543-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/b452682c0ef5/marinedrugs-18-00543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/d7348b46dd8a/marinedrugs-18-00543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/c17978ee8cca/marinedrugs-18-00543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/5ce38b650b7f/marinedrugs-18-00543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/5930e450dc77/marinedrugs-18-00543-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/4280b91908c4/marinedrugs-18-00543-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/bc5672aa6b7a/marinedrugs-18-00543-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/d006eaff7076/marinedrugs-18-00543-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/5afb91c82b9f/marinedrugs-18-00543-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/7a8b6a2d4027/marinedrugs-18-00543-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/bcb4399a7551/marinedrugs-18-00543-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/bb2b6f88c983/marinedrugs-18-00543-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/f9fc685fb0dd/marinedrugs-18-00543-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/2afaf3eb0197/marinedrugs-18-00543-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/83e3ed9617aa/marinedrugs-18-00543-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/b452682c0ef5/marinedrugs-18-00543-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/d7348b46dd8a/marinedrugs-18-00543-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/c17978ee8cca/marinedrugs-18-00543-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/5ce38b650b7f/marinedrugs-18-00543-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/5930e450dc77/marinedrugs-18-00543-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/4280b91908c4/marinedrugs-18-00543-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/bc5672aa6b7a/marinedrugs-18-00543-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/d006eaff7076/marinedrugs-18-00543-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/5afb91c82b9f/marinedrugs-18-00543-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/7a8b6a2d4027/marinedrugs-18-00543-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/bcb4399a7551/marinedrugs-18-00543-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/bb2b6f88c983/marinedrugs-18-00543-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/f9fc685fb0dd/marinedrugs-18-00543-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/2afaf3eb0197/marinedrugs-18-00543-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/500f/7693892/83e3ed9617aa/marinedrugs-18-00543-g015.jpg

相似文献

1
Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.人特异性、GalNAc/T/Tn 特异性和 Neu5Ac 特异性海藻糖凝集素作为 SARS-CoV-2(COVID-19)冠状病毒的聚糖探针。
Mar Drugs. 2020 Oct 29;18(11):543. doi: 10.3390/md18110543.
2
Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses.具有不同特异性的豆科植物凝集素作为潜在的糖探针用于致病包膜病毒。
Cells. 2022 Jan 20;11(3):339. doi: 10.3390/cells11030339.
3
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.植物、真菌、藻类和蓝藻中的人特异性凝集素,作为 SARS-CoV、MERS-CoV 和 SARS-CoV-2(COVID-19)冠状病毒的潜在阻滞剂:生物医学视角。
Cells. 2021 Jun 28;10(7):1619. doi: 10.3390/cells10071619.
4
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.SARS-CoV-2 进化适应宿主进入和识别病毒-宿主相互作用中受体 O-乙酰神经氨酸糖基化。
Int J Mol Sci. 2020 Jun 26;21(12):4549. doi: 10.3390/ijms21124549.
5
Plant lectins as versatile tools to fight coronavirus outbreaks.植物凝集素作为抗击冠状病毒爆发的多用途工具。
Glycoconj J. 2023 Feb;40(1):109-118. doi: 10.1007/s10719-022-10094-4. Epub 2022 Nov 24.
6
Mannose-specific plant and microbial lectins as antiviral agents: A review.甘露糖特异性植物和微生物凝集素作为抗病毒药物:综述。
Glycoconj J. 2024 Feb;41(1):1-33. doi: 10.1007/s10719-023-10142-7. Epub 2024 Jan 20.
7
Mannose-Specific Lectins from Marine Algae: Diverse Structural Scaffolds Associated to Common Virucidal and Anti-Cancer Properties.海洋藻类中的甘露糖特异性凝集素:与常见抗病毒和抗癌特性相关的多样化结构支架。
Mar Drugs. 2019 Jul 26;17(8):440. doi: 10.3390/md17080440.
8
Lectins from plants and algae act as anti-viral against HIV, influenza and coronaviruses.植物和藻类中的凝集素可作为抗 HIV、流感和冠状病毒的抗病毒药物。
Mol Biol Rep. 2022 Dec;49(12):12239-12246. doi: 10.1007/s11033-022-07854-8. Epub 2022 Sep 22.
9
Capture and neutralization of SARS-CoV-2 and influenza virus by algae-derived lectins with high-mannose and core fucose specificities.藻类来源的高甘露糖和核心岩藻糖特异性凝集素对 SARS-CoV-2 和流感病毒的捕获和中和作用。
Microbiol Immunol. 2023 Jul;67(7):334-344. doi: 10.1111/1348-0421.13082. Epub 2023 May 29.
10
Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.植物凝集素作为有前景的抗病毒生物分子在寻找 COVID-19 根除策略中的应用。
Biomed Pharmacother. 2022 Feb;146:112507. doi: 10.1016/j.biopha.2021.112507. Epub 2021 Dec 7.

引用本文的文献

1
Cyanobacteria Lectin (MVL) Interacts with SARS-CoV-2 Spike Protein Receptor Binding Domains (RBDs) via Protein-Protein Interaction.蓝藻凝集素 (MVL) 通过蛋白-蛋白相互作用与 SARS-CoV-2 刺突蛋白受体结合域 (RBD) 相互作用。
Int J Mol Sci. 2024 Jun 18;25(12):6696. doi: 10.3390/ijms25126696.
2
PepTraq: a toolbox for in silico data mining and fast sequence filtering.PepTraq:一个用于计算机数据挖掘和快速序列过滤的工具包。
Amino Acids. 2023 May;55(5):709-712. doi: 10.1007/s00726-023-03251-y. Epub 2023 Mar 8.
3
Seaweed-Derived Proteins and Peptides: Promising Marine Bioactives.

本文引用的文献

1
Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis.严重急性呼吸综合征冠状病毒2刺突蛋白的特征:生物物理、生化、结构和抗原分析
ACS Omega. 2020 Dec 21;6(1):85-102. doi: 10.1021/acsomega.0c03512. eCollection 2021 Jan 12.
2
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein.SARS-CoV-2 刺突蛋白的 N-和 O-糖基化。
Anal Chem. 2021 Feb 2;93(4):2003-2009. doi: 10.1021/acs.analchem.0c03173. Epub 2021 Jan 6.
3
Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.
海藻衍生的蛋白质和肽:有前景的海洋生物活性物质。
Antioxidants (Basel). 2022 Jan 17;11(1):176. doi: 10.3390/antiox11010176.
4
Marine Health-Promoting Compounds: Recent Trends for Their Characterization and Human Applications.海洋健康促进化合物:其表征及人类应用的最新趋势
Foods. 2021 Dec 14;10(12):3100. doi: 10.3390/foods10123100.
5
Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.植物凝集素作为有前景的抗病毒生物分子在寻找 COVID-19 根除策略中的应用。
Biomed Pharmacother. 2022 Feb;146:112507. doi: 10.1016/j.biopha.2021.112507. Epub 2021 Dec 7.
6
Fighting SARS-CoV-2 with green seaweed sp. extract: extraction protocol predetermines crude ulvan extract anti-SARS-CoV-2 inhibition properties in Vero-E6 cells assay.用绿藻提取物对抗严重急性呼吸综合征冠状病毒2:提取方案预先决定了粗制岩藻聚糖硫酸酯提取物在Vero-E6细胞试验中的抗严重急性呼吸综合征冠状病毒2抑制特性。
PeerJ. 2021 Nov 15;9:e12398. doi: 10.7717/peerj.12398. eCollection 2021.
7
Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection.海洋物种来源的生物活性物质在管理 SARS-CoV-2 感染中的潜在作用。
Future Microbiol. 2021 Nov;16(16):1289-1301. doi: 10.2217/fmb-2021-0024. Epub 2021 Oct 25.
8
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.植物、真菌、藻类和蓝藻中的人特异性凝集素,作为 SARS-CoV、MERS-CoV 和 SARS-CoV-2(COVID-19)冠状病毒的潜在阻滞剂:生物医学视角。
Cells. 2021 Jun 28;10(7):1619. doi: 10.3390/cells10071619.
9
Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.源自大型藻类、微藻和蓝细菌的病毒抑制剂:对整个发病过程中抗病毒潜力的综述
Algal Res. 2021 Jul;57:102331. doi: 10.1016/j.algal.2021.102331. Epub 2021 May 18.
10
New Hopes for Drugs against COVID-19 Come from the Sea.海洋为抗击新冠病毒的药物带来新希望。
Mar Drugs. 2021 Feb 11;19(2):104. doi: 10.3390/md19020104.
SARS-CoV-2 强效中和作用的结构基础及抗体亲和力成熟的作用。
Nat Commun. 2020 Oct 27;11(1):5413. doi: 10.1038/s41467-020-19231-9.
4
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.全长 SARS-CoV-2 刺突蛋白的结构分析来自一种先进的疫苗候选物。
Science. 2020 Nov 27;370(6520):1089-1094. doi: 10.1126/science.abe1502. Epub 2020 Oct 20.
5
Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白预融合结构的连续灵活性分析
IUCrJ. 2020 Sep 29;7(Pt 6):1059-69. doi: 10.1107/S2052252520012725.
6
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain.IGHV3-53 抗体与 SARS-CoV-2 受体结合域的另一种结合模式。
Cell Rep. 2020 Oct 20;33(3):108274. doi: 10.1016/j.celrep.2020.108274. Epub 2020 Sep 29.
7
The Emergence of Human Pathogenic Coronaviruses: Lectins as Antivirals for SARS-CoV-2.人致病性冠状病毒的出现:作为针对 SARS-CoV-2 的抗病毒药物的凝集素。
Curr Pharm Des. 2020;26(41):5286-5292. doi: 10.2174/1381612826666200821120409.
8
Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy.碳水化合物结合剂:在新冠病毒治疗方面的再利用潜力。
Curr Protein Pept Sci. 2020;21(11):1085-1096. doi: 10.2174/1389203721666200918153717.
9
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.通过破坏融合前刺突来中和严重急性呼吸综合征冠状病毒2
Cell Host Microbe. 2020 Sep 9;28(3):497. doi: 10.1016/j.chom.2020.07.002.
10
The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.藻类生物技术生产抗病毒化合物和生物制药的潜力。
Molecules. 2020 Sep 4;25(18):4049. doi: 10.3390/molecules25184049.